Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?
oleh: Mahesh Swaminathan, Farhad Ravandi
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2023-06-01 |
Deskripsi
No description available for this item.